Research Article | Volume: 3, Issue: 8, Supplement: 1, September, 2013

Intrahippocampal cannabinoid administration induces antinociceptive and amnestic response

Parvin Babaei and Bahram Soltani Tehrani   

Open Access   

Published:  Sep 18, 2013

DOI: 10.7324/JAPS.2013.38.S1
Abstract

In the present study, the possible role of a potent cannabinoid agonist, WIN55, 212-2 in the dorsal hippocampus on pain and memory performance has been evaluated. Animals were cannulated in CA1 region of the hippocampus using sterotaxic apparatus. Ten days after recovery, animals were trained in passive avoidance learning (PAL), and immediately received different doses of WIN 55212-2 (0.1, 0.25 and 0.5µg/rat), and were tested 24 h after the training. In the second part of the experiment animals received either WIN 55212-2 (0.5µg/rat) or saline respectively. Tail flick latency was measured three times with 10 minutes interval 30 minutes and 24 hours after the infusion into the CA1. Results indicate that post-training intra-CA1 administration of WIN55, 212-2 (0.25 and 0.5µg/rat) (P< 0.001) reduced step-down latency, showing an amnestic response. Also microinjection of WIN55212-2 (0.5ug/kg) into the CA1 region of the hippocampus induced analgesia compared to control group) (P< 0.01).


Keyword:     WIN55 212-2 Pain tail flick cannabinoids dorsal hippocampus inhibitory avoidance rat.


Citation:

Parvin Babaei and Bahram Soltani Tehrani. Intrahippocampal cannabinoid administration induces antinociceptive and amnestic response. J App Pharm Sci, 2013; 3 (8 Suppl 1): S1-S5.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Article Metrics
458 Views 14 Downloads 472 Total

Year

Month

Related Search

By author names